Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The association between adolescents' recreational screen exposure and academic performance and its mediating mechanisms.

Frontiers in public health·2026

Same author

Lineage infidelity in FH-deficient RCC with secondary somatic alterations: a case report and implications for diagnosis and treatment.

Therapeutic advances in medical oncology·2026

Same author

Characteristics and management of asthma from the China Asthma Data Registry Project.

ERJ open research·2026

Same author

Comprehensive multi-omics analysis of Mengding bud yellow tea in the intangible cultural heritage: insights into taste formation.

NPJ science of food·2026

Same author

Danthron prevents pulmonary fibrosis through improving mitochondrial function by upregulating carboxylesterase 3.

Respiratory research·2026

Same author

Response of Benthic Foraminifera to Cadmium Pollution Assessed via Morphological and Metabarcoding Analyses.

Microorganisms·2026

Search research articles

Related Experiment Video

Updated: Apr 18, 2026

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

Increased IL-33 expression in chronic obstructive pulmonary disease.

Jie Xia¹, Junling Zhao¹, Jin Shang¹

¹Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

American Journal of Physiology. Lung Cellular and Molecular Physiology

|January 18, 2015

Summary

This summary is machine-generated.

Interleukin-33 (IL-33) is elevated in chronic obstructive pulmonary disease (COPD) patients, suggesting its role in the disease's development and progression. This inflammatory mediator may be a key factor in COPD pathogenesis.

Keywords:

chronic obstructive pulmonary disease human bronchial epithelial cells interleukin-33 peripheral blood lymphocytes

More Related Videos

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

Published on: July 7, 2017

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Related Experiment Videos

Last Updated: Apr 18, 2026

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

Published on: July 7, 2017

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Area of Science:

Pulmonary Medicine
Immunology
Inflammation Biology

Background:

Chronic obstructive pulmonary disease (COPD) involves inflammation, but the role of Interleukin-33 (IL-33) is not well understood.
IL-33 is implicated in inflammatory and immunological conditions, yet its specific contribution to COPD pathogenesis requires investigation.

Purpose of the Study:

To examine IL-33 expression in COPD patients.
To determine if IL-33 contributes to the initiation and progression of COPD.

Main Methods:

Serum levels of IL-33 and its receptors (ST2, IL-1 receptor accessory protein) were quantified using ELISA.
Peripheral blood lymphocytes (PBLs) and human bronchial epithelial cells (HBEs) expressing IL-33 were analyzed via flow cytometry and immunofluorescence.
Cellular IL-33 expression was stimulated using cigarette smoke extract and lipopolysaccharide.

Main Results:

Patients with COPD exhibited significantly higher serum levels of IL-33, ST2, and IL-1 receptor accessory protein compared to controls.
Increased IL-33 expression was observed in PBLs of COPD patients.
HBEs were identified as a primary source of IL-33 in lung tissue, with expression enhanced by cigarette smoke extract and lipopolysaccharide.
PBLs from COPD patients demonstrated heightened IL-33 release upon stimulation.

Conclusions:

Elevated IL-33 levels in COPD are linked to both airway and systemic inflammation.
IL-33 plays a potential role in the pathogenesis and progression of chronic obstructive pulmonary disease.